Abstract
To facilitate the detection of carriers of a hemizygous survival motor neuron (SMN) exon 7 deletion we have modified the quantitative SMN exon 7 assay described by McAndrew et al (1997). The major changes include quantitative analysis of the amount of SMN exon 7-specific fluorescently-labelled PCR product on an automated sequencer, and the monitoring of the completeness of a DraI digestion necessary to distinguish the PCR products of exons 7 of SMN and its copy gene. In our method the amount of SMN exon 7 PCR product is compared with the amount of a co-amplified PCR product of the retinoblastoma (RB1) exon containing a DraI restriction site. By co-amplification using the same primers of plasmids included in the reaction as internal standards containing SMN exon 7 with a 36-nucleotide deletion and RB1 exon 13 with a 19-nucleotide deletion, respectively, the relative amplification efficacy can be monitored. The assay has been validated in 63 ascertained carriers and 28 ascertained non-carriers. The sensitivity of the test is approximately 97%, the specificity approaches 100%. In four out of six SMA patients without a homozygous deletion we detected a hemizygous deletion. The implications of the use of this assay for carrier testing and for confirmation of the clinical diagnosis of SMA are discussed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scheffer, H., Cobben, J., Mensink, R. et al. SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion. Eur J Hum Genet 8, 79–86 (2000). https://doi.org/10.1038/sj.ejhg.5200404
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200404
Keywords
This article is cited by
-
Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors
Journal of Genetic Counseling (2016)
-
Determination of exon 7 SMN1 deletion in Iranian patients and heterozygous carriers by quantitative real-time PCR
Journal of Genetics (2011)
-
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy
BMC Medicine (2009)
-
Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification
Neurogenetics (2006)
-
Somatic mosaicism for a heterozygous deletion of the survival motor neuron (SMN1) gene
European Journal of Human Genetics (2005)